ATE528000T1 - Verfahren und zubereitungen zur behandlung des alkoholismus und der alkoholabhängigkeit - Google Patents

Verfahren und zubereitungen zur behandlung des alkoholismus und der alkoholabhängigkeit

Info

Publication number
ATE528000T1
ATE528000T1 AT01943689T AT01943689T ATE528000T1 AT E528000 T1 ATE528000 T1 AT E528000T1 AT 01943689 T AT01943689 T AT 01943689T AT 01943689 T AT01943689 T AT 01943689T AT E528000 T1 ATE528000 T1 AT E528000T1
Authority
AT
Austria
Prior art keywords
preparations
methods
alcohol dependence
treating alcoholism
alcoholism
Prior art date
Application number
AT01943689T
Other languages
English (en)
Inventor
Abdulla Badawy
Original Assignee
Abdulla Badawy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0016056A external-priority patent/GB0016056D0/en
Priority claimed from GB0017345A external-priority patent/GB0017345D0/en
Application filed by Abdulla Badawy filed Critical Abdulla Badawy
Application granted granted Critical
Publication of ATE528000T1 publication Critical patent/ATE528000T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01943689T 2000-06-30 2001-07-02 Verfahren und zubereitungen zur behandlung des alkoholismus und der alkoholabhängigkeit ATE528000T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0016056A GB0016056D0 (en) 2000-06-30 2000-06-30 Methods and compositions for the treatment of alcoholism and alcohol dependence
GB0017345A GB0017345D0 (en) 2000-07-15 2000-07-15 Methods and compositions for the treatment of alcoholism and alcohol dependence
PCT/GB2001/002930 WO2002002091A2 (en) 2000-06-30 2001-07-02 Methods and compositions for the treatment of alcoholism and alcohol dependence

Publications (1)

Publication Number Publication Date
ATE528000T1 true ATE528000T1 (de) 2011-10-15

Family

ID=26244570

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01943689T ATE528000T1 (de) 2000-06-30 2001-07-02 Verfahren und zubereitungen zur behandlung des alkoholismus und der alkoholabhängigkeit

Country Status (7)

Country Link
US (1) US8003704B2 (de)
EP (1) EP1294377B1 (de)
JP (1) JP2004501963A (de)
AT (1) ATE528000T1 (de)
AU (1) AU2001266223A1 (de)
ES (1) ES2375347T3 (de)
WO (1) WO2002002091A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0326477D0 (en) * 2003-11-13 2003-12-17 Shs Int Ltd Medicaments for use in promoting and maintaining abstinence
EP2231149A2 (de) * 2007-11-06 2010-09-29 CV Therapeutics Inc. Aldh-2-inhibitoren bei der behandlung von psychiatrischen erkrankungen
WO2018071814A1 (en) 2016-10-14 2018-04-19 The Trustees Of Columbia University In The City Of New York Methods of treating alcohol abuse disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1172154B (it) 1981-12-15 1987-06-18 Manetti & Roberts Italo Brit Piroglutammil-triptofano e suoi derivati,procedimento per la sua preparazione e sue applicazioni terapeutiche
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse
GB9522615D0 (en) * 1995-11-03 1996-01-03 Pharmacia Spa 4-Phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
AU3899199A (en) 1998-05-12 1999-11-29 Endowment for Research in Human Biology, Inc., The Methods and assays useful in the treatment of alcohol dependence or alcohol abuse

Also Published As

Publication number Publication date
US20080076796A1 (en) 2008-03-27
EP1294377A2 (de) 2003-03-26
EP1294377B1 (de) 2011-10-12
WO2002002091A3 (en) 2002-05-02
US8003704B2 (en) 2011-08-23
JP2004501963A (ja) 2004-01-22
WO2002002091A2 (en) 2002-01-10
ES2375347T3 (es) 2012-02-29
AU2001266223A1 (en) 2002-01-14

Similar Documents

Publication Publication Date Title
NO20063373L (no) CD40-antistoff-formuleringer og fremgangsmater
ATE285809T1 (de) Vorrichtung zur verabreichung einer substanz
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
MY134586A (en) Novel pyrroles derivatives as pharmaceutical agents
DE50015623D1 (de) Kovalent verbrückte insulindimere
ATE400573T1 (de) 1h-imidazochinolinderivate als proteinkinaseinhibitoren
DE60224284D1 (de) Stabile formulierung von modifiziertem glp-1
ATE410177T1 (de) Zusammensetzung und verfahren zur rauchentgiftung
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
DE60119896D1 (de) Verwendung von pramipexol zur behandlung von tabak/nikotin abhängigkeit
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
NO20054478L (no) Framgangsmate for framstilling av syklosporin A-analog
NO20052494L (no) Preparater inneholdende melatonin, gingko biloba og biotin.
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DE502004007696D1 (de) Flavonoid-derivat
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
AU2001266223A1 (en) Methods and compositions for the treatment of alcoholism and alcohol dependence
DE602004029993D1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
EA200200987A1 (ru) Лечение заболеваний, связанных с серотонинергической системой
HRPK20040328B3 (en) Pharmaceutical composition comprising gamma-butyrobetaine
DE50113351D1 (de) Zubereitungen enthaltend einen extrakt der pflanze pistia stratiotes
ATE276363T1 (de) Metabolismuskontrolle mittels zusamensetzungen des humanen 2-oxoglutarat-trägers

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties